441 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Morrow
    Morrow
  4. Reis-Filho
    Reis-Filho
  5. Robson
    Robson
  6. Wen
    Wen
  7. Brogi
    Brogi
  8. McCormick
    McCormick
  9. Offit
    Offit
  10. Soslow
    Soslow

Groups

  1. Department of Medicine (181)
  2. Solid Tumor Oncology Division (176)
  3. Breast Medicine Service (144)
  4. Survivorship Research (122)
  5. Surgery (86)
  6. GSK Faculty (82)
  7. Department of Pathology and Laboratory Medicine (78)
  8. Population Sciences Research Program (66)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (60)
  10. Epidemiology and Biostatistics (56)
  1. "estrogen receptor"
Formats
  1. Journal Article (414)
  2. Review (14)
  3. Conference Paper (3)
  4. Editorial (3)
  5. Correspondence (2)
  6. Research Letter (2)
  7. Book Section (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (181)
  2. Solid Tumor Oncology Division (176)
  3. Breast Medicine Service (144)
  4. Survivorship Research (122)
  5. Surgery (86)
  6. GSK Faculty (82)

More Groups

People
  1. Clifford Hudis (55)
  2. Larry Norton (44)
  3. Monica Morrow (34)
  4. Jorge Reis-Filho (23)
  5. Robert Soslow (22)
  6. Mark Robson (20)

More People

Years
  1. 2025 (17)
  2. 2024 (31)
  3. 2023 (16)
  4. 2022 (18)
  5. 2021 (11)
  6. 2020 (19)

More Years

Publications
  1. Journal of Clinical Oncology (25)
  2. Annals of Surgical Oncology (23)
  3. Breast Cancer Research and Treatment (22)
  4. American Journal of Surgical Pathology (13)
  5. Annals of Oncology (13)
  6. Cancer (12)

More Publications

Publishers
  1. Springer (58)
  2. Elsevier Inc. (54)
  3. Lippincott Williams & Wilkins (34)
  4. Oxford University Press (34)
  5. Wiley Blackwell (33)
  6. Nature Publishing Group (28)

More Publishers

Results (441)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncoplastic breast-conserving surgery: Can we reduce rates of mastectomy and chemotherapy use in patients with traditional indications for mastectomy?
    Journal Article

    Crown, A.; Handy, N.; Weed, C.; Laskin, R.; Rocha, F. G.; Grumley, J.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • RNA based approaches to profile oncogenic pathways from low quantity samples to drive precision oncology strategies
    Journal Article

    van de Stolpe, A.; Verhaegh, W.; Blay, J. Y.; Ma, C. X.; Pauwels, P.; Pegram, M.; Prenen, H.; De Ruysscher, D.; Saba, N. F.; Slovin, S. F.; more...
    Frontiers in Genetics (2021)

    Fulltext@MSK | Save
  • The impact of the COVID-19 pandemic on surgical management of breast cancer: Global trends and future perspectives
    Journal Article

    Rocco, N.; Montagna, G.; Di Micco, R.; Benson, J.; Criscitiello, C.; Chen, L.; Di Pace, B.; Esgueva Colmenarejo, A. J.; Harder, Y.; Karakatsanis, A.; more...
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Evaluation of human papillomavirus (HPV) prediction using the International Endocervical Adenocarcinoma Criteria and Classification system, compared to p16 immunohistochemistry and HPV RNA in-situ hybridization
    Journal Article

    Ren, H.; Pors, J.; Chow, C.; Ta, M.; Stolnicu, S.; Soslow, R.; Huntsman, D.; Hoang, L.
    Journal of Pathology and Translational Medicine (2020)

    Fulltext@MSK | Save
  • Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
    Journal Article

    Samstein, R. M.; Krishna, C.; Ma, X.; Pei, X.; Lee, K. W.; Makarov, V.; Kuo, F.; Chung, J.; Srivastava, R. M.; Purohit, T. A.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • FOXA1 mutations reveal distinct chromatin profiles and influence therapeutic response in breast cancer
    Journal Article

    Arruabarrena-Aristorena, A.; Maag, J. L. V.; Kittane, S.; Cai, Y.; Karthaus, W. R.; Ladewig, E.; Park, J.; Kannan, S.; Ferrando, L.; Cocco, E.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer
    Journal Article

    Bitencourt, A. G. V.; Gibbs, P.; Rossi Saccarelli, C.; Daimiel, I.; Lo Gullo, R.; Fox, M. J.; Thakur, S.; Pinker, K.; Morris, E. A.; Morrow, M.; more...
    EBioMedicine (2020)

    Fulltext@MSK | Save
  • Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens
    Journal Article

    Tendl-Schulz, K. A.; Rössler, F.; Wimmer, P.; Heber, U. M.; Mittlböck, M.; Kozakowski, N.; Pinker, K.; Bartsch, R.; Dubsky, P.; Fitzal, F.; more...
    Virchows Archiv (2020)

    Fulltext@MSK | Save
  • High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities
    Journal Article

    Zou, Y.; Turashvili, G.; Soslow, R. A.; Park, K. J.; Croce, S.; McCluggage, W. G.; Stewart, C. J. R.; Oda, Y.; Oliva, E.; Young, R. H.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): A randomised, open-label, phase 2 trial
    Journal Article

    Tolaney, S. M.; Wardley, A. M.; Zambelli, S.; Hilton, J. F.; Troso-Sandoval, T. A.; Ricci, F.; Im, S. A.; Kim, S. B.; Johnston, S. R.; Chan, A.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save